America's Charities | February 4, 2019
BrightFocus-funded Alzheimer’s Test Gets Encouraging Sign from FDA
Alzheimer’s Disease Research, a BrightFocus Foundation program, has funded a blood-based screening test for Alzheimer’s disease receiving FDA Breakthrough Device Designation!
Blood-based screening tests are believed to be the first step in a multi-stage process to diagnose Alzheimer’s in people.
Special thanks to our donors for making this breakthrough possible!
Get Our Fundraising Insights Straight To Your Inbox
Explore More Articles
Get Resources and Insights Straight To Your Inbox
Receive our monthly/bi-monthly newsletter filled with information about causes, nonprofit impact, and topics important for corporate social responsibility and employee engagement professionals, including disaster response, workplace giving, matching gifts, employee assistance funds, volunteering, scholarship award program management, grantmaking, and other philanthropic initiatives.